Galenica AG engages in the provision of health care. The company is headquartered in Bern, Bern and currently employs 6,125 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Follow-Up Questions
Quelle est la performance du prix de l'action GALNF ?
Le prix actuel de GALNF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Galenica AG ?
Galenica AG appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Galenica AG ?
La capitalisation boursière actuelle de Galenica AG est de $0
Est-ce que Galenica AG est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 6 analystes ont établi des notations d'analystes pour Galenica AG, y compris 2 achat fort, 4 achat, 6 maintien, 0 vente et 2 vente forte
